IndraLab

Statements

USP4 activates Rln1. 1 / 1

| 1

reach

"Treatment with RLX siRNAs, TGF-beta1 siRNAs, Smad2 siRNAs or BB94 (MMPs inhibitor) to USP4 overexpressing breast cancer cells revealed that USP4- induced RLX via TGF-beta1 pathway promotes the cell migration and invasion."

27049265

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP4 activates Rln1. 1 / 1

INDRA sources:

Databases

Reading